...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: The Halt

It's still the same old problem:

ZENITH CAPITAL CORPORATION ("ZENI.P")

TSX Venture Tier 2 Company

 

https://www.newswire.ca/news-releases/tsx-venture-exchange-stock-maintenance-bulletins-807525017.html

 

 

ZENITH CAPITAL CORPORATION ("ZENI.P")
BULLETIN TYPE:  Halt
BULLETIN DATE:  August 4, 2021
TSX Venture Tier 2 Company

Effective at 8:09 a.m. PST, August 4, 2021, trading in the shares of the Company was halted at the request of the Company, pending news; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the Market Regulator of the Exchange pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.

Share
New Message
Please login to post a reply